Researchers receive $1,894,271 grant to address new drug targets for diastolic dysfunction

After the left ventricle of the heart contracts, it must relax efficiently to prepare to refill and supply the body with blood on the next beat. An increasing number of patients -- including nearly all patients with heart failure -- suffer from impaired relaxation, which is part of a clinical syndrome known as diastolic dysfunction. Currently, treatments for impaired relaxation do not exist.

A team of Wayne State University School of Medicine researchers led by Charles Chung, Ph.D., assistant professor of physiology, recently received a $1,894,271 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to address the critical need for new drug targets and diagnostic indexes for diastolic dysfunction using novel biomechanical tests that ultimately can be translated into clinical practice.

According to Chung, the project was inspired by his research team's finding that how quickly the heart's muscle moves is directly related to how fast the muscle can relax. The project will use unique experiments and imaging techniques to link mechanical properties of the heart with models of heart failure that occur in patients.

My lab's main research focus is to understand how the heart muscle moves at the end of contraction and how this motion can speed up the force decline, or relaxation, of the muscle. Major proteins in muscles called myosin, actin and titin control the force of each beat. When the heart muscle contracts, myosin binds to actin to generate force. Our lab is trying to determine if motion -- and how fast the motion occurs -- makes myosin let go of actin faster and make the muscle relax faster."

Charles Chung, Ph.D., Assistant Professor, Physiology, Wayne State University School of Medicine

Myosin can also be affected by other proteins like titin, which is not only the largest naturally occurring protein, which acts like a spring or rubber band within the muscle. Using titin with different stiffness levels means the team can determine if a "stiff spring" will enhance how the muscle responds (i.e. how myosin will detach) when it is moved.

To "see" what these proteins are doing when a muscle moves, the Wayne State team is collaborating with investigators from the Biological Collaborative Access Team (BioCAT) at Argonne National Laboratories and the Illinois Institute of Technologies. The combined expertise of BioCAT and Chung's lab will allow the team will use -ray diffraction to study how myosin changes position when living and beating heart muscles move.

Chung's studies of proteins within the heart muscle might also help patients with diastolic dysfunction.

"We're working with collaborators in the Department of Internal Medicine at Wayne State including Luis Afonso, M.D., chief of cardiology, and Noreen Rossi, M.D., professor in the Division of Nephrology and a researcher at the VA," said Chung. "Our work will look at how western diet staples like fructose and salt can change the movement of the heart and hinder relaxation. We're also studying how our laboratory studies might translate to the clinics, where Afonso and Rossi regularly see patients suffering from diastolic dysfunction."


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Experimental drug may slow the progression of atherosclerosis